Community based, multicenter, double-blind, randomised controlled trial comparing the effectiveness of topical ciprofloxacin and Sofradex as treatments for chronic suppurative otitis media in Aboriginal children
Conference Contribution ResearchOnline@JCUAbstract
Many Aboriginal conmmunities in rural and remote western Australia have rates of chronic suppurative otitis media (CSOM) 10 times the rate that the World Health Organization deemed as a massive public health problem in the child population. The recognition by Aboriginal leaders that the treatment of CSOM is a priority area has led to this issue being highlighted in Australia's National Aboriginal Health Strategy. In Aboriginal children, the disease usually commences in infancy within a few weeks of birth, causes hearing loss, is recurrent, can persist into adulthood, and may impact adversely on child development. Our trial aimed to compare the effectiveness of topical ciprofloxacin (0.3%) and framycetin (0.5%), gramicidin, dexamethasone (FGD, Sofradex) as treatments for CSOM in Aboriginal children. The trial was the first conmmunity controlled, multicenter, double-blind, randomized, controlled trial in Aboriginal children across the north of Australia.
Journal
N/A
Publication Name
Recent Advances in Otitis Media: Proceedings of the Eighth International Symposium June 3-7, 2003, Marriot Habor Beach Ft Lauderdale, Florida
Volume
N/A
ISBN/ISSN
978-1-55009-279-0
Edition
N/A
Issue
N/A
Pages Count
1
Location
Fort Lauderdale, FL, USA
Publisher
B.C. Decker
Publisher Url
N/A
Publisher Location
New York, NY, USA
Publish Date
N/A
Url
N/A
Date
N/A
EISSN
N/A
DOI
N/A